Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Kraeber (UK) Ltd
16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297
Contact Kraeber (UK) Ltd
Website

 Latest Content from PMHub 

PMRC New Jersey round up 2018

White Papers and Resources | March 7, 2018 | Inizio

Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey

Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis

White Papers and Resources | March 7, 2018 | Inizio

You can probably remember at least one of your friends in school who was always scratching and suffered from red, scaly skin rashes, perhaps on their elbows or backs of...

Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean

White Papers and Resources | March 7, 2018 | Inizio

In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean

How we applied user-led design thinking in the ER setting to improve patient care

White Papers and Resources | March 7, 2018 | Inizio

The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

Research conducted by Research Partnership published in leading medical journal

White Papers and Resources | March 7, 2018 | Inizio

Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

The Lucid Festival of Magic

Videos and Podcasts | March 6, 2018 | Lucid Group Communications Limited

Lucid Group threw a spellbinding event to celebrate eleven years of transforming lives with their standout new branding taking centre stage.

The Periodic Table of Healthcare Communications 2018

White Papers and Resources | March 6, 2018 | An agency called Owen

The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing.

Managing local population needs is key for the NHS

White Papers and Resources | March 6, 2018 | Wilmington Healthcare

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma

Lighthouse Medical Communications US bolster their senior scientific team

Press Releases | March 2, 2018 | Lucid Group Communications Limited

Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is pleased to announce the appointment of Marc Pondel, PhD as Executive Medical Science Director. Marc will oversee...

Vivid Medical Communications Supports the 10th Anniversary of Rare Diseases Day 2018

Press Releases | February 28, 2018 | Lucid Group Communications Limited

Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.